Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Aerobic Physical Activity in U.S. Adults: An Updated Report
In 2022, the American Academy of Audiology shared an update regarding two data briefs about physical activity in the United States. One was related to…
Adding Vestibular Training to Post-Stroke Care
A recent study by Mishra and colleagues (2026) examined individuals with chronic post-stroke disequilibrium. Participants (n=18) received either traditional balance therapy or balance therapy plus…
No Surprises Act Reform: One to Watch in the Lame-Duck Session
As Congress prepares for the lame-duck session following the November midterm elections, health care legislation could be among the issues lawmakers seek to address before…



